% \begin{savequote}[8cm]
%   Quote goes here.
%   \qauthor{--- James Wilson}
% \end{savequote}

\chapter{\label{ch:6-ea-model-results}Results: East Africa Models}
\minitoc

\section{Descriptive Analysis}

A total of 2,095 patients from nine East African studies were identified after applying the eligibility criteria to the IDDO VL data platform\cite{hailu2010,khalil2014,mbui2019,musa2010,musa2012,ritmeijer2001,ritmeijer2006,veeken2000,wasunna2016}. At the participant selection stage, 370 participants (13.5\%, 370/2749) were excluded due to either having a positive HIV test, or lacking a HIV test and recruiting from a site outside of Sudan. 323 (11.7\%, 323/2749) participants were excluded due to not achieving initial cure. A flow-diagram is presented in Figure~\ref{fig:ea_flow_diagram}.

% flow diagram
\begin{figure}[tb]
  \centering
  \includegraphics[width = 0.8\textwidth, trim={4cm 0cm 2cm 2cm}, clip]{figures/ch6/ea_flow_chart.pdf}
  \caption{Flow diagram showing the studies and participants excluded from East Africa model development, following application of the eligibility criteria. HIV: human immunodeficiency virus; IDDO: Infectious Diseases Data Observatory; EA: East Africa; PKDL: post kala-azar dermal leishmaniasis; VL: visceral leishmaniasis.}
  \label{fig:ea_flow_diagram}
\end{figure}

\subsection{Study Characteristics}

Important study characteristics are presented in Table~\ref{tab:ea_study}.

A median of 138 patients per contributed study were included in model development, ranging from 29 to 638 patients (IQR: 92 to 289 patients). Five studies recruited from sites across multiple countries (1,186 [57.8\%] patients)\cite{hailu2010,khalil2014,mbui2019,musa2012,wasunna2016}, and the remaining four studies recruited from site(s) in single countries, including Sudan (two studies, 505 [24.6\%] patients)\cite{musa2010,veeken2000} and Ethiopia (two studies 360 [17.6\%] patients)\cite{ritmeijer2006,ritmeijer2001}. A full breakdown of patients by country is included in Section~\ref{sec:pt-char} below.

The majority of studies were sponsored by DND\textit{i} and conducted across the Leishmaniasis East Africa Platform (LEAP) (six studies, 1,226 [59.8\%] patients, conducted 2004 to 2016). These included LEAP~0104 \textemdash\ a large pivotal study comparing short course SSG \& paromomycin to SSG or paromomycin monotherapy (three contributed studies, 967 [47.1\%] patients)\cite{hailu2010,musa2010,musa2012}. LEAP~0106 was a smaller study with the aim of identifying the minimum safe and effective dose of liposomal amphotericin B (LAMB) (one study, 92 [4.5\%] patients)\cite{khalil2014}. LEAP~0208 compared miltefosine with two different combination therapies (LAMB + miltefosine, LAMB + SSG) (138 [6.7\%] patients)\cite{wasunna2016}, and LEAP~0714 was a smaller allometric dosing study of miltefosine in paediatric patients (29 [1.4\%] patients)\cite{mbui2019}.

The remaining studies were led by MSF and conducted between 1998 and 2005, including two studies comparing generic and branded SSG (577 [28.1\%] patients)\cite{ritmeijer2001,veeken2000}, and a further study comparing SSG and miltefosine (248 [12.1\%] patients)\cite{ritmeijer2006}.

{
\newgeometry{left=1.5cm, right=1.5cm, top=2cm, bottom=1.8cm}

\begin{landscape}
  \pagestyle{empty}

  \input{tables/ch6/ea_study.tex}

  \begin{figure}[tb]
    \centering
    \includegraphics[width=1.35\textwidth]{figures/ch6/treat.pdf}
    \caption{Bar chart showing the distribution of treatment regimens across contributing studies from East Africa. Drugs are colour-coded (see legend). Important distinguishing dosing information provided in the overlaying labels. Full treatment details presented in Table \ref{tab:ea_study}. D: days; LAMB: liposomal amphotericin B (Gilead); PM: paromomycin; MF: miltefosine; mg: milligrams/kilogram; SSG: sodium stibogluconate.}
    \label{fig:ea_treat}
  \end{figure}

\end{landscape}
}
\pagestyle{fancy}
\restoregeometry

\subsubsection{Study Design and Treatment Arms}

All studies bar one allocated patients to more than one treatment arm (eight studies, 2,022 [98.6\%] patients)\cite{hailu2010,musa2010,musa2012,khalil2014,ritmeijer2006,ritmeijer2001,veeken2000,wasunna2016}. Six studies randomly allocated patients to treatment arms (1,445 [70.5\%] patients)\cite{hailu2010,khalil2014,musa2010,musa2012,ritmeijer2006,wasunna2016} and two studies were pseudo-randomised\footnote{Based on whether the direct agglutination test batch number was odd or even.} (577 [28.1\%] patients)\cite{ritmeijer2001,veeken2000}. Three studies were described by the authors as Phase 2 trials (207 [10.1\%] patients)\cite{mbui2019,musa2010,wasunna2016}.

Treatment arms are summarised in Figure~\ref{fig:ea_treat}. Treatment allocations at the patient level are described further in Section~\ref{sec:ea_cat_var}.

\subsubsection{Study Eligibility Criteria}

One study (248 [12.1\%] patients) limited inclusion to male patients owing to teratogenicity concerns with miltefosine\cite{ritmeijer2006}. All but two studies described age limits in their inclusion criteria\cite{hailu2010,khalil2014,mbui2019,musa2010,musa2012,ritmeijer2006,wasunna2016}. Two studies specified lower age limits only ($\geq$~15 years in one study; 248 [12.1\%] patients, and $\geq$~4 years in a further study; 92 [4.5\%] patients). Three studies limited inclusion to patients between 4 and 60 years (967 [47.1\%] patients)\cite{musa2010,musa2012,hailu2010}, and one study limited inclusion to patients between 7 and 60 years (138 [6.7\%] patients)\cite{wasunna2016}. One study recruited children between 4 and 12 years only (29 [1.4\%] patients)\cite{mbui2019}.

All DND\textit{i} studies reported exclusion criteria based on platelet count ($\geq$~40~$\times$10$^9$/L) and haemoglobin ($\geq$~40~g/L in one study, 92 [4.4\%] patients\cite{khalil2014}, and $\geq$~50~g/L in five studies, 1,134 [55.2\%] patients\cite{hailu2010,mbui2019,musa2010,musa2012,wasunna2016}).


\subsubsection{Diagnostic Criteria}
\subsubsection{Relapse}
\subsubsection{Initial Cure}
\subsection{Patient Characteristics\label{sec:pt-char}}

% these are the study specific distributions of outcome, sex and age
% cp /Users/jameswilson/proj/vl_model_ea/figures/dist/main_dist.pdf figures/ch6/ea_main_dist.pdf
\newgeometry{left=1cm, bottom=2.5cm, right=2cm, top=3cm}
\begin{landscape}
  \begin{figure}[tb]
    \centering
    \includegraphics[width=1.35\textwidth]{figures/ch6/ea_main_dist.pdf}
    \caption{Graphical summary of East Africa study-specific sample sizes and distributions of relapse status, sex, and age.}
    \label{fig:ea_main_dist}
  \end{figure}
\end{landscape}
\restoregeometry

\subsubsection{Categorical variables\label{sec:ea_cat_var}}

% categorical variables table
\input{tables/ch6/ea_categorical.tex}

\subsubsection{Continuous variables}

% continuous variables table
\input{tables/ch6/ea_continuous.tex}

% pooled distributions of categorical variables
% cp /Users/jameswilson/proj/vl_model_ea/figures/dist/catOut/comb_cat.pdf figures/ch6/ea_cat_comb.pdf
\newgeometry{left=1cm, bottom=2.5cm, right=2cm, top=3cm}
\begin{landscape}
  \begin{figure}[tb]
    \centering
    \includegraphics[width=1.35\textwidth]{figures/ch6/ea_cat_comb.pdf}
    \caption{Marginal distributions and predictor--outcomes relationships for categorical candidate predictors. Excluding missing data. 95\% binomial confidence intervals calculated using the Wilson method. Note: for parasite grade relapse \%, $y$--axis is rescaled to accommodate increased risk in 6+ group. Norm: normal.}
    \label{fig:ea_cat_comb}
  \end{figure}
\end{landscape}
\restoregeometry

\subsection{Univariable Associations}

% these are the pooled continuous distributions and relationships with relapse - PART 1
% cp /Users/jameswilson/proj/vl_model_ea/figures/dist/contOut/age_comb.pdf figures/ch6/ea_pool_age_comb.pdf
% cp /Users/jameswilson/proj/vl_model_ea/figures/dist/contOut/ss_comb.pdf figures/ch6/ea_pool_ss_comb.pdf
% cp /Users/jameswilson/proj/vl_model_ea/figures/dist/contOut/fd_comb.pdf figures/ch6/ea_pool_fd_comb.pdf
% cp /Users/jameswilson/proj/vl_model_ea/figures/dist/contOut/height_comb.pdf figures/ch6/ea_pool_height_comb.pdf
% cp /Users/jameswilson/proj/vl_model_ea/figures/dist/contOut/weight_comb.pdf figures/ch6/ea_pool_weight_comb.pdf

\clearpage
\begin{figure}[H]
  \centering
  \begin{subfigure}{\textwidth}
    \centering
    \begin{overpic}[width=\textwidth]{figures/ch6/ea_pool_age_comb.pdf}
      \put(2,19){\small Age}
    \end{overpic}
  \end{subfigure}
  \begin{subfigure}{\textwidth}
    \centering
    \begin{overpic}[width=\textwidth]{figures/ch6/ea_pool_weight_comb.pdf}
      \put(2,19){\small Weight}
    \end{overpic}
  \end{subfigure}
  \begin{subfigure}{\textwidth}
    \centering
    \begin{overpic}[width=\textwidth]{figures/ch6/ea_pool_height_comb.pdf}
      \put(2,19){\small Height}
    \end{overpic}
  \end{subfigure}
  \begin{subfigure}{\textwidth}
    \centering
    \begin{overpic}[width=\textwidth]{figures/ch6/ea_pool_fd_comb.pdf}
      \put(2,19){\small FevDur}
    \end{overpic}
  \end{subfigure}
  \begin{subfigure}{\textwidth}
    \centering
    \begin{overpic}[width=\textwidth]{figures/ch6/ea_pool_ss_comb.pdf}
      \put(2,19){\small SpnSize}
    \end{overpic}
  \end{subfigure}
  \caption{Distributions and predictor--outcome relationships for continuous non-laboratory candidate predictors. FevDur:~duration of fever; SpnSize:~spleen size. For each candidate predictor, left upper panel shows the overall density across studies and the left lower panel shows overlapping densities normalised by relapse status. The right panel shows a univariable generalised additive model spline fit, with 95\% confidence interval, of relapse.}
  \label{fig:ea_pooled_dist_cont1}
\end{figure}

% these are the pooled continuous distributions and relationships with relapse - PART 2
% cp /Users/jameswilson/proj/vl_model_ea/figures/dist/contOut/wbc_comb.pdf figures/ch6/ea_pool_wbc_comb.pdf
% cp /Users/jameswilson/proj/vl_model_ea/figures/dist/contOut/plt_comb.pdf figures/ch6/ea_pool_plt_comb.pdf
% cp /Users/jameswilson/proj/vl_model_ea/figures/dist/contOut/hb_comb.pdf figures/ch6/ea_pool_hb_comb.pdf
% cp /Users/jameswilson/proj/vl_model_ea/figures/dist/contOut/alt_comb.pdf figures/ch6/ea_pool_alt_comb.pdf
% cp /Users/jameswilson/proj/vl_model_ea/figures/dist/contOut/cr_comb.pdf figures/ch6/ea_pool_cr_comb.pdf
\begin{figure}[H]
  \centering
  \begin{subfigure}{\textwidth}
    \centering
    \begin{overpic}[width=\textwidth]{figures/ch6/ea_pool_hb_comb.pdf}
      \put(2,19){\small Hb}
    \end{overpic}
  \end{subfigure}
  \begin{subfigure}{\textwidth}
    \centering
    \begin{overpic}[width=\textwidth]{figures/ch6/ea_pool_plt_comb.pdf}
      \put(2,19){\small Plt}
    \end{overpic}
  \end{subfigure}
  \begin{subfigure}{\textwidth}
    \centering
    \begin{overpic}[width=\textwidth]{figures/ch6/ea_pool_wbc_comb.pdf}
      \put(2,19){\small WBC}
    \end{overpic}
  \end{subfigure}
  \begin{subfigure}{\textwidth}
    \centering
    \begin{overpic}[width=\textwidth]{figures/ch6/ea_pool_alt_comb.pdf}
      \put(2,19){\small ALT}
    \end{overpic}
  \end{subfigure}
  \begin{subfigure}{\textwidth}
    \centering
    \begin{overpic}[width=\textwidth]{figures/ch6/ea_pool_cr_comb.pdf}
      \put(2,19){\small Crt}
    \end{overpic}
  \end{subfigure}
  \caption{Marginal distributions and predictor--outcome relationships for continuous laboratory candidate predictors. All predictors presented on log scale. Hb:~haemoglobin; Plt:~platelet; WBC:~white blood cells; ALT:~alanine aminotransferase; Crt:~creatinine. For each candidate predictor, left upper panel shows the overall density across studies and the left lower panel shows overlapping densities normalised by relapse status. The right panel shows a univariable generalised additive model spline fit, with 95\% confidence interval, of relapse.}
  \label{fig:ea_pooled_dist_cont2}
\end{figure}

\subsection{\label{sec:isc_missing_data}Missing Data}

\subsubsection{Multiple Imputation}

% missing data figure
% cp /Users/jameswilson/proj/vl_model_ea/figures/missing/summary.pdf figures/ch6/ea_missing_summary.pdf
\begin{figure}[tb]
  \centering
  \includegraphics[scale = 0.8, trim={0cm 3.8cm 0cm 3.3cm}, clip]{figures/ch6/ea_missing_summary.pdf}
  \caption{Density plot illustrating the amount of missing data overall and across contributing studies from East Africa. Study ordered by lead author and publication year. Variables ordered by amount of missingness. ALT: alanine aminotransferase; WBC: white blood cells.}
  \label{fig:ea_missing_summary}
\end{figure}

\section{Model Results}

\subsection{Model Specification and Coefficient Estimates}


% cp /Users/jameswilson/proj/vl_model_ea/results/var_forest_combined.pdf figures/ch6/var_forest_combined.pdf
\begin{figure}[tb]
  \centering
  \includegraphics[width=\textwidth]{figures/ch6/var_forest_combined.pdf}
  \caption{Forest plot of adjusted odds ratios with 95\% confidence intervals for final model predictors. Odds ratios are displayed on a logarithmic scale.}
  \label{fig:ea_var_forest_combined}
\end{figure}


% cp /Users/jameswilson/proj/vl_model_ea/figures/multiAssocM1.pdf figures/ch6/isc_multiassoc_with_pg.pdf
% cp /Users/jameswilson/proj/vl_model_ea/figures/multiAssocM2.pdf figures/ch6/isc_multiassoc_without_pg.pdf
\newgeometry{left=2.5cm, bottom=2.3cm, right=2cm, top=2.8cm}
\begin{landscape}
  \begin{figure}[tb]
    \centering
    \begin{subfigure}{1.5\textwidth}
      \centering
      \begin{overpic}[width=\textwidth]{figures/ch6/isc_multiassoc_without_pg.pdf}
        \put(2,25.5){\small\textbf{East Africa model: without parasite grade}}
      \end{overpic}
    \end{subfigure}
    \begin{subfigure}{1.5\textwidth}
      \centering
      \begin{overpic}[width=\textwidth]{figures/ch6/isc_multiassoc_with_pg.pdf}
        \put(2,22.4){\small\textbf{East Africa model: with parasite grade}}
      \end{overpic}
    \end{subfigure}
    \caption{Adjusted associations between final predictors and predicted relapse probability, as estimated from the final East Africa prognostic models. Probabilities were calculated from optimism--adjusted models and following logistic recalibration (intercept--term only) to data contributed from Musa 2012\cite{musa2012}. Where not varying in the plot, predictions are standardised to a representative reference participant: median age (13 years), median fever duration (45 days), median white cell count (2.5 x10$^9$/L), with severe anaemia, moderate malnutrition, and \textemdash\ for the model including parasite grade \textemdash\ a median parasite count of 2+.}
    \label{fig:ea_adjusted_assoc}
  \end{figure}
\end{landscape}
\restoregeometry

\subsection{Model Performance and Internal Validation}


\begin{table}[htbp]
  \begin{tabular}{@{}llll@{}}
    \toprule
                                   & Performance        & Average  & Optimism--adjusted \\
                                   & estimate (95\% CI) & optimism & performance        \\        \midrule
    \textbf{Model: with PG}        &                    &          &                    \\
    \hspace{1em} C-statistic       & 0.72 (0.63--0.82)  & 0.046    & 0.68               \\
    \hspace{1em} Calibration slope & 1.03 (0.64--1.42)  & 0.224    & 0.81               \\        \midrule
    \textbf{Model: without PG}     &                    &          &                    \\
    \hspace{1em} C-statistic       & 0.66 (0.56--0.76)  & 0.050    & 0.61               \\
    \hspace{1em} Calibration slope & 1.08 (0.47--1.68)  & 0.329    & 0.75               \\        \bottomrule
  \end{tabular}
  \caption{Apparent and optimism--adjusted performance measures. Abbreviations: CI: confidence interval; PG: parasite grade}
  \label{tab:ea-performance}
\end{table}


% cp /Users/jameswilson/proj/vl_model_ea/graphs/forestCIM1.pdf figures/ch6/forestCIM1.pdf
% forest plots for C-statistic
\begin{figure}[tb]
  \centering
  \begin{overpic}[width=\textwidth, trim={3.5cm 0cm 1cm 0.3cm}, clip]{figures/ch6/forestCIM1.pdf}
    \put(0,5.5){\fcolorbox{black}{white}{\scriptsize $\tau^2$ = 0.0040; $I^2$ = 46.6\%; p = 0.11}}
  \end{overpic}
  \caption{Forest plot showing individual and pooled study c--statistics, for the model \textbf{including} parasite grade. For the model excluding parasite grade refer to Appendix \ref{fig:ea_forestCIM2}. Pooled c--statistics are presented from both fixed--effects and random--effects meta-analysis models, after excluding studies with $\leq$ 5 relapse events. Study--specific confidence intervals with few events should be interpreted with caution (as discussed in the Methodology \ref{meth:discrimination}). Blue diamonds: pooled summary estimates with 95\% confidence intervals. For Mbui 2019, all bootstrapped c--statistic estimates were 1 exactly and therefore no variance is presented.}
  \label{fig:ea_forestCIM1}
\end{figure}

% cp /Users/jameswilson/proj/vl_model_ea/graphs/forestCalM1.pdf figures/ch6/forestCalM1.pdf
% forest plots for calibration
\begin{figure}[tb]
  \centering
  \begin{overpic}[width=\textwidth, trim={2.4cm 0cm 0.3cm 0.3cm}, clip]{figures/ch6/forestCalM1.pdf}
    \put(0,12){\fcolorbox{black}{white}{\tiny CITL: $\tau^2$ = 0.960; $I^2$ = 89.0\%; p < .0001}}
    \put(0,8.85){\fcolorbox{black}{white}{\tiny CS: $\tau^2$ = 0; $I^2$ = 0\%; p = 0.90}}
  \end{overpic}
  \caption{Forest plots showing individual and pooled study calibration measures for the model \textbf{including} parasite grade. Left: calibration intercept (calibration--in--the--large, CITL); Right: calibration slope (CS). Blue diamonds: summary estimates with 95\% confidence intervals. Calibration slope for Mbui 2019 not shown due to small sample size causing failure of model convergence.}
  \label{fig:ea_forestCalM1}
\end{figure}

% calibration plots (overall)
% cp /Users/jameswilson/proj/vl_model_ea/graphs/calPlot.pdf figures/ch6/ea_calPlot.pdf
\begin{figure}[tb]
  \centering
  \begin{overpic}[width=\textwidth, trim = 0 0 0 -25]{figures/ch6/ea_calPlot.pdf}
    \put(2,52){\small\textbf{East Africa model: with parasite grade}}
    \put(50,52){\small\textbf{East Africa model: without parasite grade}}
  \end{overpic}
  \caption{Calibration plots showing observed versus predicted probabilities for deciles of predicted probability. Red dashed line represents perfect calibration.  Observed probabilities are presented with 95\% confidence intervals (black error bars). A generalised additive model is fitted to show the smoothed mean observed probability (blue dotted line) with 95\% confidence intervals (blue ribbon). Histograms, normalised by outcome, are overlaid to illustrate the distribution of relapses and cures across the expected probabilities.}
  \label{fig:ea_calPlot}
\end{figure}

% calibration plots (malnutrition)
% cp /Users/jameswilson/proj/vl_model_ea/graphs/calPlotMal1.pdf figures/ch6/ea_calPlotMal1.pdf
\begin{figure}[tb]
  \centering
  \includegraphics[width=\textwidth]{figures/ch6/ea_calPlotMal1.pdf}
  \caption{Calibration plots for malnutrition severity (model including parasite grade).}
  \label{fig:ea_calPlotMal1}
\end{figure}

\section{Summary}